SAVE CANADIANS NOW.

Your Name 123 Your Street Your City, Prov A1B 2C3 (123) 456-7890 no_reply@example.com July 7, 2020 Patented Medicine Price Review Board Box L40 Standard Life Centre 333 Laurier Avenue West Suite 1400 Ottawa, Ontario K1P 1C1 PMPRB Consultation Feedback Submission I am writing to you as part of the consultation period to the most recently revised changes to the PMPRB guidelines released June 2020. Our family is directly impacted by these changes as the lifesaving drug Trikafta to treat Cystic Fibrosis has not been submitted to Canada. The reason the manufacturer has not submitted Trikafta is directly related to the PMPRB changes. Our request is that guidelines be revised to encourage the drug submission thereby enabling Cystic Fibrosis patients access to Trikafta and future innovative therapies. ADD YOUR STORY, 3-4 SENTENCES REALLY SHOWING THE HUMAN SIDE “My son’s life is at stake. He was diagnosed with CF at xxx and he has been fighting for the last xxx years to stay healthy. The drug Trikafta is the hope we’ve been waiting for our whole lives. All we want is for him to grow old and live a full life.” Please take into consideration ALL Canadians before implementing policy changes that ultimately decide who lives and who dies. Sincerely, Name CF Get Loud Advocate Send